Literature DB >> 29101630

Biotin Thiamin Responsive Basal Ganglia Disease in Siblings.

Vykuntaraju K Gowda1, Varunvenkat M Srinivasan2, Maya Bhat3, Naveen Benakappa2.   

Abstract

Biotin Thiamine responsive Basal Ganglia Disease (BTBGD) is a rare treatable autosomal recessive metabolic disorder caused by mutations in SLC19A3 gene. It usually presents with encephalopathy and dystonia; if not treated, can progress to quadriparesis and death. Two Indian siblings born to a consanguineous marriage presented with regression of milestones, epilepsy and dystonia. Neuroimaging showed signal changes in basal ganglia and thalami. Genetic testing showed a homozygous missense substitution p.Gly23Val (c.68G > T) in exon 2 of the SLC19A3 gene. Thus to conclude, any child who presents with neuroregression, epilepsy and dystonia in the background of basal ganglia changes on neuroimaging, a possibility of biotin thiamine responsive basal ganglia disease should be considered.

Entities:  

Keywords:  Biotin thiamine responsive basal ganglia disease; Dystonia; Neuroregression; SLC19A3 gene

Mesh:

Substances:

Year:  2017        PMID: 29101630     DOI: 10.1007/s12098-017-2471-5

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  9 in total

1.  Mutations in a thiamine-transporter gene and Wernicke's-like encephalopathy.

Authors:  Satoshi Kono; Hiroaki Miyajima; Kenichi Yoshida; Akashi Togawa; Kentaro Shirakawa; Hitoshi Suzuki
Journal:  N Engl J Med       Date:  2009-04-23       Impact factor: 91.245

2.  Biotin thiamine responsive basal ganglia disease-A potentially treatable inborn error of metabolism.

Authors:  Karthik Muthusamy; Alka V Ekbote; Maya M Thomas; Sanjith Aaron; Vivek Mathew; Anil B Patil; Ajith Sivadasan; A T Prabhakar; Sangeetha Yoganathan; Mathew Alexander
Journal:  Neurol India       Date:  2016 Nov-Dec       Impact factor: 2.117

3.  Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3.

Authors:  Wen-Qi Zeng; Eiman Al-Yamani; James S Acierno; Susan Slaugenhaupt; Tammy Gillis; Marcy E MacDonald; Pinar T Ozand; James F Gusella
Journal:  Am J Hum Genet       Date:  2005-05-03       Impact factor: 11.025

4.  Reversible lactic acidosis in a newborn with thiamine transporter-2 deficiency.

Authors:  Belén Pérez-Dueñas; Mercedes Serrano; Mónica Rebollo; Jordi Muchart; Eva Gargallo; Celine Dupuits; Rafael Artuch
Journal:  Pediatrics       Date:  2013-04-15       Impact factor: 7.124

5.  Biotin-responsive basal ganglia disease: a treatable and reversible neurological disorder of childhood.

Authors:  P S Bindu; M L Noone; A Nalini; Uday B Muthane; Jerry M E Kovoor
Journal:  J Child Neurol       Date:  2009-06       Impact factor: 1.987

6.  Biotin-responsive basal ganglia disease revisited: clinical, radiologic, and genetic findings.

Authors:  Brahim Tabarki; Shatha Al-Shafi; Saad Al-Shahwan; Zeeshan Azmat; Amel Al-Hashem; Nawal Al-Adwani; Nabil Biary; Mohamed Al-Zawahmah; Sonia Khan; Giulio Zuccoli
Journal:  Neurology       Date:  2012-12-26       Impact factor: 9.910

7.  Biotin-responsive basal ganglia disease: a novel entity.

Authors:  P T Ozand; G G Gascon; M Al Essa; S Joshi; E Al Jishi; S Bakheet; J Al Watban; M Z Al-Kawi; O Dabbagh
Journal:  Brain       Date:  1998-07       Impact factor: 13.501

Review 8.  Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases.

Authors:  Majid Alfadhel; Makki Almuntashri; Raafat H Jadah; Fahad A Bashiri; Muhammad Talal Al Rifai; Hisham Al Shalaan; Mohammed Al Balwi; Ahmed Al Rumayan; Wafaa Eyaid; Waleed Al-Twaijri
Journal:  Orphanet J Rare Dis       Date:  2013-06-06       Impact factor: 4.123

9.  A wide spectrum of clinical and brain MRI findings in patients with SLC19A3 mutations.

Authors:  Kenichiro Yamada; Kiyokuni Miura; Kenju Hara; Motomasa Suzuki; Keiko Nakanishi; Toshiyuki Kumagai; Naoko Ishihara; Yasukazu Yamada; Ryozo Kuwano; Shoji Tsuji; Nobuaki Wakamatsu
Journal:  BMC Med Genet       Date:  2010-12-22       Impact factor: 2.103

  9 in total
  1 in total

Review 1.  Report of the Largest Chinese Cohort With SLC19A3 Gene Defect and Literature Review.

Authors:  Jiaping Wang; Junling Wang; Xiaodi Han; Zhimei Liu; Yanli Ma; Guohong Chen; Haoya Zhang; Dan Sun; Ruifeng Xu; Yi Liu; Yuqin Zhang; Yongxin Wen; Xinhua Bao; Qian Chen; Fang Fang
Journal:  Front Genet       Date:  2021-07-01       Impact factor: 4.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.